- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 6, 2026 | 2.14M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 1.37M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 261.59K sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.61M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.59M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $3.72M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $5.28M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $2.13M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $4.07M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.51M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.4M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.51M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.4M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $4.8M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $6.18M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $5.23M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $6.67M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.48 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$8.52 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.48 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$8.52 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.57M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.52M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $432.53K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $746.89K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.02M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.23M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$2M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$2.27M |